On Wednesday, August 26, 2026, from 1:00 PM JST, our CEO/CSO Satoshi Tamaki will speak at the 8th VC Consortium Special Event hosted by Shonan Health Innovation Park (Shonan iPark).

The event will bring together business development professionals from pharmaceutical companies, VC/CVC investors, and startups to discuss applications of AI in drug discovery and healthcare, as well as new businesses leveraging the platforms and capabilities of trading companies. In Session 1, Tamaki will introduce MOLCURE’s work in AI-driven drug discovery.

The event will be held in a hybrid format, with both in-person and online participation, and will be conducted in Japanese. Online participation is free, with no registration deadline.

For more details and registration, please visit the official event page.